Panbela Therapeutics (PBLA) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Panbela Therapeutics, Inc. has announced its return to compliance with Nasdaq’s listing requirements regarding bid price and the number of publicly held shares. This milestone is critical for the company’s continued presence on the stock market, ensuring its shares meet the necessary standards for trading and ownership distribution.
For further insights into PBLA stock, check out TipRanks’ Stock Analysis page.